Savant Capital’s Nektar Therapeutics NKTR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$319K Buy
12,364
+10,164
+462% +$263K ﹤0.01% 1341
2025
Q1
$22.4K Buy
+2,200
New +$22.4K ﹤0.01% 1571